To identify imaging markers predicting clinical outcomes to regorafenib in metastatic colorectal carcinoma (mCRC).
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)
FALCONE, ALFREDO;CREMOLINI, CHIARA;
2016-01-01
Abstract
To identify imaging markers predicting clinical outcomes to regorafenib in metastatic colorectal carcinoma (mCRC).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
